Daniel Patrick O'Day - 10 Dec 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chairman & CEO, Director
Signature: /s/ Edward S. Son by Power of Attorney for Daniel P. O'Day
Issuer symbol: GILD
Transactions as of: 10 Dec 2024
Net transactions value: -$439,723
Form type: 4
Filing time: 11 Dec 2024, 19:13:55 UTC
Previous filing: 11 Sep 2024
Next filing: 06 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+10,295	+2.1%		506,290	10 Dec 2024	Direct	F1
transaction	GILD	Common Stock	Tax liability	$439,723	-4,762	-0.94%	$92.34	501,528	10 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-10,295	-8.9%		104,977	10 Dec 2024	Common Stock	10,295		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.